[ad_1]
ATMOS Inc. has received FDA clearance for its innovative ATMOS C 051 Cardiothoracic Digital Drain and Observation System, a medical device designed to optimize recovery for patients undergoing lung resection surgery. This digital drainage system provides clinicians with real-time, objective data on air leaks, which is a critical factor in determining when chest tubes can be safely removed. The innovation has the potential to reduce hospital stays and accelerate patient recovery.
A key differentiator of the C 051 is its automatic active tube clearance mechanism, which eliminates the need for manual intervention to prevent blood clots. Unlike conventional drainage systems that restrict mobility by tethering patients to wall suction, the ATMOS C 051 Cardiothoracic Digital Drain and Observation System features a compact, lightweight design that promotes early ambulation.
For patients with persistent air leaks, the device can be used in home-based recovery under physician supervision. Additionally, the device incorporates an AI-powered QR code support system to provide instant troubleshooting guidance for medical staff without requiring external assistance.
Image Credit: ATMOS Inc.
[ad_2]
Source link
